MSB 0.77% 97.3¢ mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-347

  1. 3,762 Posts.
    lightbulb Created with Sketch. 357
    efficacy has not been verified.

    a bunch of specialist, selected by the FDA, voted 9-1 in favour of Rem. Primary being EFFICACY.

    unbelievable!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.3¢
Change
-0.008(0.77%)
Mkt cap ! $1.124B
Open High Low Value Volume
98.0¢ 98.5¢ 96.0¢ $2.780M 2.850M

Buyers (Bids)

No. Vol. Price($)
52 161482 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 36945 17
View Market Depth
Last trade - 13.27pm 26/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.